Skip to content
Incorporating Immunotherapy for Patients with Operable Esophageal and GE Junction Adenocarcinoma
October 10, 2025
Presenter: Dr. Samuel J. Klempner
Please Provide Your Feedback to Help us Improve Future Programs
OK
1.
How likely is it that you would recommend this ECAN webinar to a friend or family member?
Not at all likely - 0
1
2
3
4
5
6
7
8
9
Extremely likely - 10
Not at all likely - 0
1
2
3
4
5
6
7
8
9
Extremely likely - 10
2.
Overall, how would you rate the webinar?
Excellent
Very good
Good
Fair
Poor
3.
How much did you know about the topic before the webinar?
I had no understanding of the topic
I was very knowledgeable about the topic
I had no understanding of the topic
I was very knowledgeable about the topic
4.
How much did you learn about the topic during the webinar?
I didn't learn anything new about the topic
I learned a great deal about the topic
I didn't learn anything new about the topic
I learned a great deal about the topic
5.
How likely is it that the knowledge gained in this webinar will impact how you make healthcare decisions in the future?
Not at all likely - 0
1
2
3
4
5
6
7
8
9
Extremely likely - 10
Not at all likely - 0
1
2
3
4
5
6
7
8
9
Extremely likely - 10
6.
How likely is it that you will discuss the knowledge gained in this webinar with your healthcare providers in the future?
Not at all likely - 0
1
2
3
4
5
6
7
8
9
Extremely likely - 10
Not at all likely - 0
1
2
3
4
5
6
7
8
9
Extremely likely - 10
7.
How helpful to you was the content presented in the webinar?
Extremely helpful
Very helpful
Somewhat helpful
Not so helpful
Not at all helpful
8.
How engaging was the expert presenter in the webinar?
Extremely engaging
Very engaging
Somewhat engaging
Not so engaging
Not at all engaging
9.
How engaging was the moderator for the webinar?
Extremely engaging
Very engaging
Somewhat engaging
Not so engaging
Not at all engaging
10.
How likely are you to attend an ECAN webinar again in the future?
Extremely likely
Very likely
Somewhat likely
Not so likely
Not at all likely
11.
What other topics would you like to see future ECAN webinars address?
12.
Please share any other comments, questions, or concerns you may have.
Current Progress,
0 of 12 answered
